Medicis Pharmaceutical Corp. (MRX) Tops Q4 EPS by 15c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $65.15 -1.06%
EPS Growth %: +22.5%
Financial Fact:
Depreciation and amortization: 18.32M
Today's EPS Names:
FCNCA, PBCO, ARBV, More
EPS Growth %: +22.5%
Financial Fact:
Depreciation and amortization: 18.32M
Today's EPS Names:
FCNCA, PBCO, ARBV, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q4 EPS of $0.76, $0.15 better than the analyst estimate of $0.61. Revenue for the quarter came in at $415.6 million versus the consensus estimate of $370.72 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA Committee Recommends To Widen Access To Bpc-157 Peptide
- Trump Says He's Close To Decision On Massive Iran Attack - Axios
- Kearny Financial (KRNY) Misses Q4 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
